支气管肺发育不良:驻留肺干细胞何去何从?起源与(潜在)功能
支气管肺发育不良(BPD)是极早产儿在急性呼吸衰竭接受机械通气和氧疗后发生的慢性肺疾病,2017年迎来其50周年,仍是极早产儿最常见的并发症。随着更早胎龄早产儿存活率提高,肺损伤预防愈发困难。BPD被推测为发育中肺的多种功能(生长因子信号、基质及细胞组成)发生错误导向,导致肺泡和肺血管生长受损。尽管对正常肺发育调控机制的理解有所进步,BPD仍无治疗方法。干细胞生物学研究揭示了干细胞的修复潜力,模拟BPD的动物模型临床前研究显示基于干细胞的疗法具有肺保护作用,已推动早期临床试验;但作者认为开展设计良好的早期临床试验的时机已成熟,仍需更多了解这些细胞的生物学以开发安全、高效、高质量的临床级细胞产品。
要点
- BPD仍是极早产儿最常见的并发症,2017年为该病50周年,目前仍无治疗方法。
- BPD被推测为发育中肺的生长因子信号、基质及细胞组成等多功能错误导向,导致肺泡和肺血管生长受损。
- 模拟BPD的动物模型临床前研究显示基于干细胞的疗法具有肺保护作用,已推动早期临床试验。
- 作者认为开展设计良好的早期临床试验的时机已成熟,但仍需更多了解这些细胞的生物学以开发安全、高效、高质量的临床级细胞产品。
- 驻留肺干细胞耗竭/功能障碍可能参与未成熟肺自我修复能力的不足,理解正常肺干细胞功能及其在BPD中的扰动可能有助于设计修复能力更强的优质细胞产品。
适用人群与场景
- 极早产儿,尤其是出生胎龄越来越早、存活率提高的早产儿,在急性呼吸衰竭接受机械通气和氧疗后发生慢性肺疾病(BPD)者。
研究设计与关键结果
- 本文为综述,未报告原始研究样本量或效应量;文中汇总的证据包括:BPD是极早产儿最常见的并发症,2017年为该病50周年;BPD被推测为发育中肺的多功能错误导向(生长因子信号、基质及细胞组成),导致肺泡和肺血管生长受损;干细胞生物学研究揭示了干细胞的修复潜力;模拟BPD的动物模型临床前研究显示基于干细胞的疗法具有肺保护作用,已推动早期临床试验。
证据类型、等级与局限
- 证据类型:综述;文中汇总了临床前动物模型研究和早期临床试验的证据,未报告证据等级或推荐强度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为开展设计良好的早期临床试验的时机已成熟,但仍需更多了解这些细胞的生物学以开发安全、高效、高质量的临床级细胞产品。
- 作者认为理解正常肺干细胞功能及其在BPD中的扰动可能有助于设计修复能力更强的优质细胞产品,以确保基础研究成功转化为临床实践。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Celebrating its 50th anniversary in 2017, bronchopulmonary dysplasia (BPD)-the chronic lung disease of prematurity that follows ventilator and oxygen therapy for acute respiratory failure-remains the most frequent complication of extreme prematurity. Survival of premature infants born at increasingly earlier stages of gestation has made the prevention of lung injury increasingly challenging. BPD is postulated to be a misdirection of many functions in the developing lung, including growth factor signalling and matrix as well as cellular composition, resulting in impaired alveolar and lung vascular growth. Despite improvements in understanding the mechanisms that regulate normal lung development, BPD remains without therapies. Insights into stem cell biology have identified the repair potential of stem cells. Promising preclinical studies demonstrated the lung protective effects of stem cell-based therapies in animal models mimicking BPD, leading to early-phase clinical trials. Although the time is ripe to conduct well-designed early-phase clinical trials, much more needs to be learned about the biology of these cells to develop safe, efficient, high-quality, clinical-grade cell products. Stem cells are essential for normal organ development, maintenance, and repair. It is therefore biologically plausible that exhaustion/dysfunction of resident lung stem cells contributes to the inability of the immature lung to repair itself. Understanding how normal lung stem cells function and how these cells are perturbed in BPD may prove useful in designing superior cell products with enhanced repair capabilities to ensure the successful translation of basic research into clinical practice.
参考来源
- Möbius MA, Thébaud B. Bronchopulmonary Dysplasia: Where Have All the Stem Cells Gone?: Origin and (Potential) Function of Resident Lung Stem Cells. Chest. 2017. PMID: 28479114. doi:10.1016/j.chest.2017.04.173
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。